September 2024
Features
Changing of the guard
BBH’s combination of offensive and defensive qualities looks attractive…
23 Sep
23 Sep
Features
Green green grass
Why the biotech sector is bouncing back to rude health…
19 Sep
19 Sep
Fund Research
Bellevue Healthcare
BBH looks set for a recovery as interest rates fall…
26 Sep
26 Sep
August 2024
Strategy
Dream team
Our analysts review how their fund picks for 2024 have done…
28 Aug
28 Aug
Blog
Don’t look back in anger
US equities are worth rolling with, but the market is broadening…
31 Aug
31 Aug
Trusts in focus
Trusts in Focus: Bellevue Healthcare
We give you the lowdown on healthcare specialist BBH...
06 Aug
06 Aug
July 2024
Strategy
A really great stockmarket, the best, some tell me the best they’ve ever seen
US equities should be the bedrock of any diversified portfolio…
03 Jul
03 Jul
Blog
Ch-ch-ch-changes
Politics isn’t the only place where there are big changes at the top, but for shareholders change is often a good thing…
13 Jul
13 Jul
March 2024
Strategy
How to grow old gracefully (and preferably rich)...
Ahead of the final week of our event, focused on retirement planning, we consider some of the complexities of portfolio construction…
20 Mar
20 Mar
Strategy
Roller coaster ride
Thematic funds have seen significant outflows over the past two years…
13 Mar
13 Mar
Blog
Healthcare, UK valuations, and renewables
We take a look back at the final week of our ISA event…
28 Mar
28 Mar
Blog
Trend setters
We take a look at four mega-trends to future-proof your portfolio…
22 Mar
22 Mar
Features
Bouncing back to rude health
IBT is well-positioned to exploit the attractive valuations on offer in the biotech sector…
06 Mar
06 Mar
Features
Behind the trust: International Biotechnology Trust plc
Biotech companies stand to inject high returns and positive social impact into an investor’s portfolio and International Biotechnology Trust has an impressive track record of doing this with lower volatility than the index (NASDAQ Biotechnology Index), while paying a healthy dividend yield...
01 Mar
01 Mar
News
Results analysis: Bellevue Healthcare
Reviewing a tough financial year, but the last three months give grounds for optimism...
05 Mar
05 Mar
Fund Research
Bellevue Healthcare
BBH could be poised for strong performance as the rate cycle eases…
21 Mar
21 Mar
February 2024
Guides
Investing in biotechnology with investment trusts
How investment trusts can provide investors with access to the high-growth biotech sector…
27 Feb
27 Feb
Video
Talking Trusts: An introduction to investing in biotech with International Biotechnology Trust
We talk about what IBT offers for investors looking for exposure to the biotech sector…
27 Feb
27 Feb
Features
Waiting for the world to change
Closed-ended trusts are a simple way to access the attractive income and defensive potential of renewables infrastructure…
20 Feb
20 Feb
October 2023
Strategy
Computer says no
Markets are fixated on replacing humans with AI, rather than maintaining them with biotech. Could this be an opportunity to rotate profits?
18 Oct
18 Oct
Features
Staying on course in a volatile sector
IBT's has delivered superior returns with lower volatility than the wider market...
13 Oct
13 Oct
September 2023
Blog
Healthy fundamentals
Healthcare and biotech are out of favour despite the secular growth trends supporting them…
29 Sep
29 Sep
Trust Issues
A biotech bounce back? With IBT Manager Ailsa Craig - Podcast: Trust Issues #22
We talk the move to Schroders, managing risk, and reinvesting the proceeds of M&A activity...
28 Sep
28 Sep
Blog
Pizza Tiger
You don’t need to reinvent the wheel to deliver good returns on your investment...
15 Sep
15 Sep
Fund Research
International Biotechnology
IBT managers’ unique approach set to continue at Schroders…
15 Sep
15 Sep